Results 11 to 20 of about 6,312 (217)

Immune checkpoint blockade in HIV

open access: yesEBioMedicine, 2022
Summary: Antiretroviral therapy (ART) has dramatically improved life expectancy for people with HIV (PWH) and helps to restore immune function but is not curative and must be taken lifelong.
Celine Gubser   +3 more
doaj   +5 more sources

Immune checkpoint blockade therapy [PDF]

open access: yesJournal of Allergy and Clinical Immunology, 2018
Immune checkpoints are accessory molecules that either promote or inhibit T-cell activation. Two inhibitory molecules, cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1), got high attention, as inhibition of CTLA-4 or PD-1 signaling provides the first immune therapy that significantly improves the survival of patients ...
Thomas, Wieder   +3 more
openaire   +2 more sources

Radiotherapy Complements Immune Checkpoint Blockade [PDF]

open access: yesCancer Cell, 2015
Adaptive immune resistance ablates effective anti-tumor immune responses. In a recent issue of Nature, Victor and colleagues describe that anti-PD-L1 combats adaptive immune resistance upon localized radiation plus anti-CTLA-4 therapy. The superior activity of radiation and dual immune checkpoint blockade is mediated by non-redundant immune mechanisms ...
Ngiow, Shin Foong   +2 more
openaire   +5 more sources

Neutrophils in the era of immune checkpoint blockade [PDF]

open access: yesJournal for ImmunoTherapy of Cancer, 2021
The immune checkpoint blockade-based immunotherapies are revolutionizing cancer management. Tumor-associated neutrophils (TANs) were recently highlighted to have a pivotal role in modulating the tumor microenvironment and the antitumor immune response.
Faget, Julien   +4 more
openaire   +7 more sources

Immune checkpoint blockade in infectious diseases [PDF]

open access: yesNature Reviews Immunology, 2017
The upregulation of immune checkpoint molecules, such as programmed cell death protein 1 (PD1) and cytotoxic T lymphocyte antigen 4 (CTLA4), on immune cells occurs during acute infections, such as malaria, as well as during chronic persistent viral infections, including HIV and hepatitis B virus.
Wykes, MN, Lewin, SR
openaire   +3 more sources

Immune-Checkpoint Blockade Therapy in Lymphoma [PDF]

open access: yesInternational Journal of Molecular Sciences, 2020
Tumor cells use immune-checkpoint pathways to evade the host immune system and suppress immune cell function. These cells express programmed cell-death protein 1 ligand 1 (PD-L1)/PD-L2, which bind to the programmed cell-death protein 1 (PD-1) present on cytotoxic T cells, trigger inhibitory signaling, and reduce cytotoxicity and T-cell exhaustion ...
Ayumi Kuzume   +3 more
openaire   +2 more sources

Immune checkpoint blockade in ovarian cancer [PDF]

open access: yesmemo - Magazine of European Medical Oncology, 2016
Increased numbers of tumour infiltrating T‑cells have long been associated with a better prognosis in ovarian cancer, which has led to the general assumption of a relevant impact of T‑cellular anti-tumour immunity in this disease. As a consequence of this knowledge, a multitude of immunologic therapies has emerged over the past years.
Weiss, Lukas   +3 more
openaire   +2 more sources

Renal complications of immune checkpoint blockade [PDF]

open access: yesCurrent Problems in Cancer, 2017
Immune checkpoint inhibitors have been approved for a variety of cancer species. Renal complications in use of these agents are not very common compared with other immune-related adverse events (irAE). However, it is crucial for physicians to recognize and manage renal manifestations of irAE.
Naoka, Murakami   +2 more
openaire   +2 more sources

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma

open access: yesNature Communications, 2021
Immune-checkpoint blockade has shown limited benefits in patients with glioblastoma. To understand how the composition of the tumor immune microenvironment might limit clinical responses, here the authors present a high dimensional profiling of the ...
Alexander H. Lee   +13 more
doaj   +1 more source

Corticosteroids and immune checkpoint blockade

open access: yesAging, 2015
Novel immunotherapies acting through immune checkpoint blockade to stimulate the immune response have demonstrated promising outcomes in advanced malignancies [1]. As a result, novel cancer immunotherapy was named a scientific breakthrough of the year in 2013 by Science.
Le, Min   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy